(Press-News.org) University of Maryland School of Medicine (UMSOM) researchers have shown that psilocybin--the active chemical in "magic mushrooms"-- still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is blocked. The new findings suggest that psychedelic drugs work in multiple ways in the brain and it may be possible to deliver the fast-acting antidepressant therapeutic benefit without requiring daylong guided therapy sessions. A version of the drug without, or with less of, the psychedelic effects could loosen restrictions on who could receive the therapy, and lower costs, making the benefits of psilocybin more available to more people in need.
In all clinical trials performed to date, the person treated with psilocybin remains under the care of a guide, who keeps the person calm and reassures them during their daylong experience. This can include hallucinations, altered perception of time and space, and intense emotional and spiritual encounters.
Researchers in the field have long attributed psilocybin's effectiveness to the intense psychedelic experience.
"We do not understand the mechanisms that underlie the antidepressant actions of psilocybin and the role that the profound psychedelic experience during these sessions plays in the therapeutic benefits," says Scott Thompson, Ph.D., Professor and Chair, Department of Physiology at UMSOM and senior author of the study. "The psychedelic experience is incredibly powerful and can be life-changing, but that could be too much for some people or not appropriate."
Several barriers prevent the wide-spread use of psychedelic compounds. For example, there is fear that the psychedelic experience may promote psychosis in people who are predisposed to severe mental disorders, like bipolar disorder and schizophrenia, so the clinical therapy sessions performed to-date have been limited to a highly selected screened group without a family history of these disorders.
Dr. Thompson adds that there may also be an equity issue because not everyone can take several days off work to prepare and engage in the experience. The costs of staffing a facility with at least one trained guide per treated person per day and a private space may also be prohibitive to all but a few. He says it is conceivable that a depression treatment derived from psilocybin could be developed without the psychedelic effects so people can take it safely at home without requiring a full day in a care facility.
For their study, led by UMSOM MD/PhD student Natalie Hesselgrave, the team used a mouse model of depression in which mice were stressed for several hours a day over 2-3 weeks. Because researchers cannot measure mouse moods, they measure their ability to work for rewards, such as choosing to drink sugar water over plain water. People suffering from depression lose the feeling of pleasure for rewarding events. Similarly, stressed mice no longer preferred sugar water over plain water. However, 24 hours after a dose of psilocybin, the stressed mice regained their preference for the sugar water, demonstrating that the drug restored the mice's pleasure response.
Psilocybin exerts its effects in people by binding to and turning on receptors for the chemical messenger serotonin. One of these receptors, the serotonin 2A receptor, is known to be responsible for the psychedelic response. To see if the psychedelic effects of psilocybin were needed for the anti-depressive benefits, the researchers treated the stressed mice with psilocybin together with a drug, ketanserin, which binds to the serotonin 2A receptor and keeps it from being turned on. The researchers found that the stressed mice regained their preference for the sugar water in response to psilocybin, even without the activation of the psychedelic receptor.
"These findings show that activation of the receptor causing the psychedelic effect isn't absolutely required for the antidepressant benefits, at least in mice," says Dr. Thompson, "but the same experiment needs to be performed in depressed human subjects." He says his team plans to investigate which of the 13 other serotonin receptors are the ones responsible for the antidepressant actions.
"This new study has interesting implications, and shows that more basic research is needed in animals to reveal the mechanisms for how these drugs work, so that treatments for these devastating disorders can be developed" says Albert E. Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, University of Maryland Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine.
INFORMATION:
This work was funded by the National Institute of Mental Health (R01 MH086828) and the National Institute of General Medical Sciences (T32 GM092237).
Although not approved yet, Dr. Thompson and the University of Maryland Baltimore have filed a patent on using psilocybin with drugs that block serotonin 2A receptors to treat depression.
About the University of Maryland School of Medicine
Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 45 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.2 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for nearly 2 million patients each year. The School of Medicine has more than $563 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 student trainees, residents, and fellows. The combined School of Medicine and Medical System ("University of Maryland Medicine") has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu
The "three-body problem," the term coined for predicting the motion of three gravitating bodies in space, is essential for understanding a variety of astrophysical processes as well as a large class of mechanical problems, and has occupied some of the world's best physicists, astronomers and mathematicians for over three centuries. Their attempts have led to the discovery of several important fields of science; yet its solution remained a mystery.
At the end of the 17th century, Sir Isaac Newton succeeded in explaining the motion of the planets around the sun through ...
PLYMOUTH MEETING, PA [April 13, 2021] -- The April 2021 issue of JNCCN--Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer. The researchers studied 1,689 patients with metastatic renal cell carcinoma (mRCC) who had been considered for clinical trial participation at either of the two institutions between 2001 and 2019 and had undergone brain imaging in this context, without clinical suspicion for brain involvement. The researchers discovered 4% had asymptomatic brain metastases in this setting. This group was found to have a low median 1-year ...
ITHACA, N.Y. - We've all seen them: political ads on television that promise doom gloom if Candidate X is elected, and how all your problems will be solved if you choose Candidate Y. And Candidate Y, of course, approves this message.
Beyond attempting to move a large swath of the population to vote one way or another, the seemingly constant bombardment of negativity in the name of our democratic process is anxiety-inducing, researchers have found.
"Many of my friends and family members wind up quite stressed out, for lack of a better word, during each election season," said Jeff Niederdeppe, professor in the Department of Communication in the College of ...
With 'Eyecam' they now present the prototype of a webcam that not only looks like a human eye, but imitates its movements realistically. "The goal of our project is not to develop a 'better' design for cameras, but to spark a discussion. We want to draw attention to the fact that we are surrounded by sensing devices every day. That raises the question of how that affects us," says Marc Teyssier. In 2020, the French scientist completed his doctorate on the topic of anthropomorphic design in Paris. Now he is a postdoctoral researcher in the Human-Computer Interaction Lab at Saarland University in Germany.
The research team at Saarland Informatics Campus has developed ...
Human non-alcoholic fatty liver disease (NAFLD) is a little-understood condition that significantly increases the risk of inflammation, fibrosis and liver cancer and ultimately requires liver transplant.
"NAFLD has been difficult to study mainly because we had no good animal model," said corresponding author Dr. Karl-Dimiter Bissig, who was at Baylor during the development of this project and is now at Duke University.
The disease has both genetic and nutritional components, which have been hard to understand in human studies, and murine models ...
A new study verifies the age and origin of one of the oldest specimens of Homo erectus--a very successful early human who roamed the world for nearly 2 million years. In doing so, the researchers also found two new specimens at the site--likely the earliest pieces of the Homo erectus skeleton yet discovered. Details are published today in the journal Nature Communications.
"Homo erectus is the first hominin that we know about that has a body plan more like our own and seemed to be on its way to being more human-like," said Ashley Hammond, an assistant curator in the American Museum of Natural History's Division of Anthropology and the lead author of the new study. "It had longer lower limbs than upper limbs, a torso ...
ITHACA, N.Y. - The muon is a tiny particle, but it has the giant potential to upend our understanding of the subatomic world and reveal an undiscovered type of fundamental physics.
That possibility is looking more and more likely, according to the initial results of an international collaboration - hosted by the U.S. Department of Energy's Fermi National Accelerator Laboratory - that involved key contributions by a Cornell team led by Lawrence Gibbons, professor of physics in the College of Arts and Sciences.
The collaboration, which brought together 200 scientists from 35 institutions in seven countries, set out to confirm the findings of a 1998 experiment that startled physicists by indicating that muons' magnetic ...
In the Cascadia subduction zone, medium and large-sized "intraslab" earthquakes, which take place at greater than crustal depths within the subducting plate, will likely produce only a few detectable aftershocks, according to a new study.
The findings could have implications for forecasting aftershock seismic hazard in the Pacific Northwest, say Joan Gomberg of the U.S. Geological Survey and Paul Bodin of the University of Washington in Seattle, in their paper published in the Bulletin of the Seismological Society of America.
Researchers now calculate aftershock forecasts in the region based in part on data from subduction zones around the world. ...
In a series of experiments that began with amoebas -- single-celled organisms that extend podlike appendages to move around -- Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated to help sweep out mucus from the lungs of people with chronic obstructive pulmonary disease a widespread lung ailment.
"Physician-scientists and fundamental biologists worked together to understand a problem at the root of a major human illness, and the problem, as often happens, relates to the core biology of cells," says Doug Robinson, Ph.D., professor of cell ...
Circularly polarized light exhibits promising applications in future displays and photonic technologies. Traditionally, circularly polarized light is converted from unpolarized light by the linear polarizer and the quarter-wave plate. During this indirectly physical process, at least 50% of energy will be lost. Circularly polarized luminescence (CPL) from chiral luminophores provides an ideal approach to directly generate circularly polarized light, in which the energy loss induced by polarized filter can be reduced. Among various chiral luminophores, organic micro-/nano-structures have attracted increasing attention owing to the high quantum efficiency ...
